Want to see TSE:NEVI full AI Analyst Report?

Pascal Biosciences Inc (NEVI) Price & Analysis

5 Followers

NEVI Stock Chart & Stats

C$0.07

C$0.00(0.00%)

At close: Jan 07 4:00 PM EST

C$0.07

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.02 - C$0.10

Previous CloseN/A

Volume0.00

Average Volume (3M)55.49K

Market Cap

C$991.57K

Enterprise ValueC$1.23M

Total Cash (Recent Filing)C$102.17K

Total Debt (Recent Filing)C$244.21K

Price to Earnings (P/E)―

Beta2.01

Next Earnings

Jul 23, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding39,662,727

10 Day Avg. Volume84,932

30 Day Avg. Volume55,489

Financial Highlights & Ratios

PEG Ratio0.26

Price to Book (P/B)2.05

Price to Sales (P/S)1.17

P/FCF Ratio31.93

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained acceleration in top-line growth and a smaller net loss indicate the business is gaining traction and improving unit economics. Over a 2–6 month horizon, continued revenue scaling can support operating leverage, help absorb fixed costs, and reduce future funding needs if trends persist.

Improved Cash FlowThe shift to positive operating and free cash flow represents a structural improvement in cash conversion and discipline. Even modest positive cash flow reduces reliance on external financing, bolsters short-term liquidity, and can fund incremental growth or margin-improvement initiatives if sustained.

Lower LeverageDeclining leverage and a positive equity base improve financial flexibility and reduce interest burden risk. This stronger balance sheet foundation lowers refinancing risk, supports investment choices, and makes management better able to execute strategic initiatives over the medium term.

Bears Say

Gross Margin CompressionA dramatic decline in gross margin signals structural pressure from costs, pricing, or product mix that directly impairs sustainable profitability. Unless management can restore margin via pricing power, cost reductions, or higher-margin products, the company faces persistent margin vulnerability over coming quarters.

Ongoing LossesDespite improvement, continued negative net margins mean the company is not yet self-sustaining. Persistent losses erode retained equity and constrain reinvestment capacity; absent durable margin recovery, the firm may need external capital, which can dilute stakeholders or limit strategic flexibility.

Modest, Volatile Cash GenerationCurrent positive cash flow is small relative to historical volatility and cumulative losses, indicating fragile cash generation. If operating cash flow reverts to prior negative levels, the company could face liquidity stress and need fresh funding, making execution risk elevated over the medium term.

Pascal Biosciences Inc News

Nevis Brands Expands Market Presence and Strengthens Financial Position

The latest announcement is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. has announced significant...

7M ago

Nevis Brands Expands Major™ Cannabis Beverage Line in U.S. Markets

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an announcement. Nevis Brands Inc. has announced the expansion of...

8M ago

Nevis Brands Reports 16% Revenue Growth in Q3 2025 Amid Market Expansion

An update from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc. reported a 16%...

9M ago

Nevis Brands Inc. Secures Strong Shareholder Support at AGM

The latest update is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. announced the successful...

10M ago

Nevis Brands Expands Major™ Cannabis Beverages to New Mexico

An announcement from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc. has announced a...

10M ago

Nevis Brands Expands Midwest Reach with Strategic Distribution Agreement

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an announcement. Nevis Brands Inc. has announced a strategic distribution...

12M ago

Nevis Brands Sees Revenue Growth Amid New Product Launches

The latest announcement is out from Pascal Biosciences Inc ( ($TSE:NEVI) ). Nevis Brands Inc. reported a slight...

12M ago

Nevis Brands Expands Cannabis Beverage Offerings in Illinois and the Carolinas

Pascal Biosciences Inc ( ($TSE:NEVI) ) has provided an announcement. Nevis Brands Inc has launched its Major™ 100mg...

1y ago

Nevis Brands Reports 61% Revenue Growth in Q1 2025

An update from Pascal Biosciences Inc ( ($TSE:NEVI) ) is now available. Nevis Brands Inc reported a significant...

1y ago

Nevis Brands Inc Reports Strong Fiscal Year 2024 Results with Market Expansion

Pascal Biosciences Inc ( ($TSE:NEVI) ) has shared an update. Nevis Brands Inc reported a significant increase in...

1y ago

NEVI FAQ

What was Pascal Biosciences Inc’s price range in the past 12 months?

Pascal Biosciences Inc lowest stock price was C$0.02 and its highest was C$0.10 in the past 12 months.

What is Pascal Biosciences Inc’s market cap?

Pascal Biosciences Inc’s market cap is C$991.57K.

When is Pascal Biosciences Inc’s upcoming earnings report date?

Pascal Biosciences Inc’s upcoming earnings report date is Jul 23, 2026 which is in 17 days.

How were Pascal Biosciences Inc’s earnings last quarter?

Currently, no data Available

Is Pascal Biosciences Inc overvalued?

According to Wall Street analysts Pascal Biosciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pascal Biosciences Inc pay dividends?

Pascal Biosciences Inc does not currently pay dividends.

What is Pascal Biosciences Inc’s EPS estimate?

Pascal Biosciences Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pascal Biosciences Inc have?

Pascal Biosciences Inc has 39,662,727 shares outstanding.

What happened to Pascal Biosciences Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Pascal Biosciences Inc?

Currently, no hedge funds are holding shares in TSE:NEVI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Pascal Biosciences Inc

Nevis Brands Inc. engages in the development and sale of cannabis products in the United States. It offers hemp derived THC beverages under the Major brand name. The company was formerly known as Pascal Biosciences Inc. and changed its name to Nevis Brands Inc. in June 2023. Nevis Brands Inc. is headquartered in Seattle, Washington.